Paradigm Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,200
Closed -$83.9K 418
2022
Q1
$83.9K Hold
1,200
0.02% 360
2021
Q4
$93.4K Sell
1,200
-200
-14% -$17.7K 0.02% 352
2021
Q3
$134K Sell
1,400
-100
-7% -$10.6K 0.04% 312
2021
Q2
$186K Sell
1,500
-200
-12% -$23.9K 0.05% 314
2021
Q1
$224K Sell
1,700
-200
-11% -$27.4K 0.06% 314
2020
Q4
$252K Buy
+1,900
New +$230K 0.07% 313

Other funds holding EXAS

Paradigm Asset Management's EXAS Position: Q2 2022 in Review

Paradigm Asset Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 1,200 shares — an estimated $83.9K sold.

Paradigm Asset Management first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $252K in Q4 2020. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Paradigm Asset Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Paradigm Asset Management sold 1,200 Exact Sciences shares in Q2 2022, an estimated $83.9K.
  • Paradigm Asset Management first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Paradigm Asset Management's Exact Sciences position peaked at $252K in Q4 2020.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Paradigm Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.